Shantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...

Mid-cap IT stocks faced a significant downturn Wednesday, led by KPIT Technologies' warning of a near-term revenue slowdown. This has ampli...

US stock market today July 1: US markets experienced a mixed trading day as the Dow Jones briefly hit a new intraday record before retreati...

Shutterstock shares plunged nearly 30% after Getty Images scrapped its $3.7 billion merger following UK regulator objections. The Competiti...

Indian stock markets surged on Wednesday, breaking a two-day losing spell. Positive global sentiment and other factors propelled investor c...

Australian shares kicked off the new financial year on a downbeat note, with banks leading the decline following disappointing housing pric...

Chinese stocks are experiencing a significant downturn in 2026, with the MSCI China Index plummeting 15%, marking its worst performance glo...

Indian equities ended lower for the second straight session as benchmarks slipped on expiry-day volatility, though broader markets advanced...

Waaree Energies shares fell nearly 5% after a US Customs ruling triggered concerns over reputational impact despite the company’s clarifica...

Initial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...

Healthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...

The Bombay High Court has cancelled Thane-based Menschlich Healthcare's trademark 'Duphachrit' in favour of Abbott Product Operations AG. T...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

The benchmark snapped a four-day losing streak on Thursday, as ⁠investors digested the European Central Bank's rate hike and largely looked...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

Danish drugmaker Novo Nordisk has confirmed a security incident. Unauthorised access to internal IT systems occurred. Certain non-public da...

India's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...